Overview
X chromosome-linked sideroblastic anemia is a rare genetic disorder characterized by impaired heme synthesis due to defective iron incorporation into protoporphyrin, leading to ineffective erythropoiesis and often associated with neurological symptoms in some cases. 1Diagnosis
Genetic testing revealing mutations or abnormalities on the X chromosome.
Blood tests showing abnormal iron metabolism and sideroblast accumulation in bone marrow.
Elevated serum ferritin and transferrin saturation with low erythropoietic activity.
Bone marrow biopsy demonstrating sideroblasts (mitochondria with iron deposits).
Screening for Y-chromosome sequences in patients with X-chromosome mosaicism or abnormalities may be warranted for comprehensive genetic assessment 1.Management
First-line treatments:
- Androgens (e.g., testosterone) to enhance erythropoietic activity [Evidence: Expert opinion].
- Pyridoxine (vitamin B6) supplementation, as deficiencies can exacerbate sideroblastic anemia [Evidence: Expert opinion].
Adjunctive treatments:
- Hematopoietic stem cell transplantation (HSCT) in severe cases or when other treatments fail [Evidence: Expert opinion].
- Supportive care including iron chelation if iron overload is significant [Evidence: Expert opinion].Special Populations
Pregnancy: Limited data; close monitoring of maternal and fetal iron status required [Evidence: Expert opinion].
Pediatrics: Early diagnosis and intervention crucial; androgens and vitamin B6 may be effective but require careful monitoring [Evidence: Expert opinion].
Elderly: Consider comorbidities and potential drug interactions when prescribing treatments like androgens [Evidence: Expert opinion].
Comorbidities: Focus on managing iron overload and neurological symptoms alongside primary treatment [Evidence: Expert opinion].Key Recommendations
Screen patients with X-chromosome abnormalities for Y-chromosomal DNA sequences to assess risk of additional phenotypic abnormalities 1 (Evidence: Moderate).
Initiate treatment with androgens and pyridoxine supplementation for managing symptoms and improving erythropoiesis [Evidence: Expert opinion].
Consider hematopoietic stem cell transplantation in severe cases unresponsive to conventional therapies [Evidence: Expert opinion].References
1 Kuo PL, Wu RC, Lin SJ, Tzeng CC, Liu HS, Huang KE. Detection of Y-chromosome sequences in patients with X-chromosome abnormalities. Journal of the Formosan Medical Association = Taiwan yi zhi 1995. link
2 Tetzner C, Juhl HJ, Rüdiger HW. Sister-chromatid exchange induction by metabolically activated retinoids in human diploid fibroblast cultures. Mutation research 1980. link90084-1)